Targeting IDH1-Mutated Oligodendroglioma with Acid Ceramidase Inhibitors
Muley Vilamu, H.; Dowdy, T.; Zaibaq, F.; Karadimov, G.; Li, A.; Song, H.; Zhang, M.; Zhang, W.; Wong, Z.; Zhang, L.; Lita, A.; Larion, M.
Show abstract
Oligodendroglioma is genetically defined as a tumor harboring isocitrate dehydrogenase 1 or 2 mutations (IDH1mut/IDH2mut) and 1p/19q co-deletions. Previously, we reported that in IDH1mut gliomas, D-2HG, the product of IDH1 mutant enzyme produces an increase in monounsaturated fatty acid levels that are incorporated into ceramides, tilting the S1P-to-ceramide rheostat toward apoptosis. Herein, we exploited this imbalance to further induce and IDHmut-specific glioma cell death. We report for the first time that the inhibition of acid ceramidase (AC) induces apoptosis and provides a benefit in mice survival in IDH1mut oligodendroglioma. We demonstrated an IDH1mut-specific cytotoxicity of SABRAC, an irreversible inhibitor of AC, in patient-derived oligodendroglioma cells. Exploring the mechanism of action of this drug, we found that SABRAC activates both extrinsic and intrinsic apoptosis in an ER stress-independent manner, pointing to a direct action of AC-related ceramides in mitochondria permeability. The activation of apoptosis detected under SABRAC treatment was associated with up to 30-fold increase in some ceramide levels and its derivatives from the salvage pathway. We propose that this novel enzyme, AC, has the potential to increase survival in oligodendroglioma with IDH1mut and should be considered in the future.
Matching journals
The top 16 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- FYN tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates anti-glioma immune responses 94%
- High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in SHH-medulloblastoma 93%
- Advancing Clinical Response Against Glioblastoma: Evaluating SHP1705 CRY2 Activator Efficacy in Preclinical Models and Safety in Phase I Trials 93%
Similar papers in this journal
- Novel Adult Cortical Neuron Processing and Screening method illustrates Sex- and Age-dependent effects of pharmaceutical compounds 94%
- Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis 93%
- Rapid Resistance To Bet Inhibitors Is Mediated By Fgfr1 In Glioblastoma 93%
Similar papers in this journal
- Disruption of redox balance in glutaminolytic triple negative breast cancer by inhibition of glutamate export and glutaminase 93%
- P53-independent restoration of p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9 93%
- Identification of BET Inhibitors (BETi) Against Solitary Fibrous Tumor (SFT) Through High-Throughput Screening (HTS) 92%
Similar papers in this journal
- An unbiased high-throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer 93%
- Cysteine is a limiting factor for glioma proliferation and survival 93%
- NOX4 regulates TGFβ-induced proliferation and self-renewal in glioblastoma stem cells. 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.